These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 38447684)

  • 1. Comprehensive multi-omics analysis and experimental verification reveal PFDN5 is a novel prognostic and therapeutic biomarker for gastric cancer.
    Shao Y; Yesseyeva G; Zhi Y; Zhou J; Zong J; Zhou X; Fan X; Li S; Huang L; Zhang S; Dong F; Yang X; Zheng M; Sun J; Ma J
    Genomics; 2024 Mar; 116(2):110821. PubMed ID: 38447684
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prefoldin subunits (PFDN1-6) serve as poor prognostic markers in gastric cancer.
    Yesseyeva G; Aikemu B; Hong H; Yu C; Dong F; Sun J; Zang L; Zheng M; Ma J
    Biosci Rep; 2020 Feb; 40(2):. PubMed ID: 31957800
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prefoldin 5 and Anti-prefoldin 5 Antibodies as Biomarkers for Uveitis in Ankylosing Spondylitis.
    Kwon OC; Lee EJ; Lee JY; Youn J; Kim TH; Hong S; Lee CK; Yoo B; Robinson WH; Kim YG
    Front Immunol; 2019; 10():384. PubMed ID: 30891043
    [No Abstract]   [Full Text] [Related]  

  • 4. Identification of novel prognostic biomarkers by integrating multi-omics data in gastric cancer.
    Liu N; Wu Y; Cheng W; Wu Y; Wang L; Zhuang L
    BMC Cancer; 2021 Apr; 21(1):460. PubMed ID: 33902514
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integration of transcriptomics, proteomics, and metabolomics data to reveal HER2-associated metabolic heterogeneity in gastric cancer with response to immunotherapy and neoadjuvant chemotherapy.
    Yuan Q; Deng D; Pan C; Ren J; Wei T; Wu Z; Zhang B; Li S; Yin P; Shang D
    Front Immunol; 2022; 13():951137. PubMed ID: 35990657
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multi-omics data of gastric cancer cell lines.
    Seo EH; Shin YJ; Kim HJ; Kim JH; Kim YS; Kim SY
    BMC Genom Data; 2023 Apr; 24(1):24. PubMed ID: 37081404
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of three lncRNA-related prognostic signatures in gastric cancer by integrated multi-omics analysis.
    Jiang H; Wang J; Song Y; Chen J; Dong L; Xu Q; Cao R; Wang Y; Xu X; Zhang X; Kong F; Guan M; Deng X
    Epigenomics; 2023 Dec; 15(24):1293-1308. PubMed ID: 38126139
    [No Abstract]   [Full Text] [Related]  

  • 8. Lysine demethylase 5C inhibits transcription of prefoldin subunit 5 to activate c-Myc signal transduction and colorectal cancer progression.
    Yu F; Li L; Gu Y; Wang S; Zhou L; Cheng X; Jiang H; Huang Y; Zhang Y; Qian W; Li X; Liu Z
    Mol Med; 2024 Jan; 30(1):9. PubMed ID: 38216914
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integrative analysis of epigenomics, transcriptomics, and proteomics to identify key targets and pathways of Weining granule for gastric cancer.
    Liang MK; Liang XQ; Zhong J; Wei YT; Lian ZP; Huang ZK; Liang J
    J Ethnopharmacol; 2021 Apr; 270():113787. PubMed ID: 33422657
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comprehensive Multiomics Analyses Establish the Optimal Prognostic Model for Resectable Gastric Cancer : Prognosis Prediction for Resectable GC.
    Guo S; Wang E; Wang B; Xue Y; Kuang Y; Liu H
    Ann Surg Oncol; 2024 Mar; 31(3):2078-2089. PubMed ID: 37996637
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comprehensive genomic meta-analysis identifies intra-tumoural stroma as a predictor of survival in patients with gastric cancer.
    Wu Y; Grabsch H; Ivanova T; Tan IB; Murray J; Ooi CH; Wright AI; West NP; Hutchins GG; Wu J; Lee M; Lee J; Koo JH; Yeoh KG; van Grieken N; Ylstra B; Rha SY; Ajani JA; Cheong JH; Noh SH; Lim KH; Boussioutas A; Lee JS; Tan P
    Gut; 2013 Aug; 62(8):1100-11. PubMed ID: 22735568
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of the Prefoldin Subunit 5 Gene Deletion in Canine Mammary Tumors.
    Hennecke S; Beck J; Bornemann-Kolatzki K; Neumann S; Murua Escobar H; Nolte I; Hammer SC; Hewicker-Trautwein M; Junginger J; Kaup FJ; Brenig B; Schütz E
    PLoS One; 2015; 10(7):e0131280. PubMed ID: 26132936
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of GNG7 as a novel biomarker and potential therapeutic target for gastric cancer via bioinformatic analysis and
    Duan H; Chen B; Wang W; Luo H
    Aging (Albany NY); 2023 Feb; 15(5):1445-1474. PubMed ID: 36863706
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular classification reveals the diverse genetic and prognostic features of gastric cancer: A multi-omics consensus ensemble clustering.
    Hu X; Wang Z; Wang Q; Chen K; Han Q; Bai S; Du J; Chen W
    Biomed Pharmacother; 2021 Dec; 144():112222. PubMed ID: 34607103
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of CLC-3 is regulated by XRCC5 and is a poor prognostic biomarker for gastric cancer.
    Gu Z; Li Y; Yang X; Yu M; Chen Z; Zhao C; Chen L; Wang L
    J Hematol Oncol; 2018 Sep; 11(1):115. PubMed ID: 30217218
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prefoldin-5 Expression Is Elevated in Eutopic and Ectopic Endometriotic Epithelium and Modulates Endometriotic Epithelial Cell Proliferation and Migration In Vitro.
    Nothnick WB; Cui W; Falcone T; Graham A
    Int J Mol Sci; 2024 Feb; 25(4):. PubMed ID: 38397067
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comprehensive analysis of the function of helicobacter-associated ferroptosis gene YWHAE in gastric cancer through multi-omics integration, molecular docking, and machine learning.
    Liu D; Peng J; Xie J; Xie Y
    Apoptosis; 2024 Apr; 29(3-4):439-456. PubMed ID: 38001345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Construction of an immune-related risk score signature for gastric cancer based on multi-omics data.
    Wang Y; Huang W; Zheng S; Wang L; Zhang L; Pei X
    Sci Rep; 2024 Jan; 14(1):1422. PubMed ID: 38228846
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Knockout of UBE2S inhibits the proliferation of gastric cancer cells and induces apoptosis by FAS-mediated death receptor pathway.
    Zhao R; Yu Z; Mao X; Zheng Y; Wang Y; Zhou Y
    Exp Cell Res; 2022 Oct; 419(1):113293. PubMed ID: 35863455
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miRNA-194 predicts favorable prognosis in gastric cancer and inhibits gastric cancer cell growth by targeting CCND1.
    Wang J; Zhang M; Hu X; She J; Sun R; Qin S; Li D
    FEBS Open Bio; 2021 Jul; 11(7):1814-1826. PubMed ID: 33605558
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.